Weakness after Velagliflozin (Senvelgo) in cats

48 reports to the FDA describe weakness in cats given Velagliflozin. That is 1.0% of all reports for this medicine, compared with 1.2% across reports for all cat medicines.

48Reports

60%Marked serious

10%Recovered

44%Died or euthanised

7 daysTypical onset

How soon it started

Same day

5 11%

1–2 days

12 27%

3–7 days

6 14%

1–4 weeks

11 25%

Over a month

10 23%

How the animals did

Recovered

5 10%

Still unwell when reported

6 13%

Died

9 19%

Euthanised

12 25%

Not known

16 33%

Problems reported at the same time

23 48%

22 46%

21 44%

19 40%

16 33%

16 33%

12 25%

12 25%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Velagliflozin cause weakness in cats?: 48 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 7 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Weakness with similar medicines

Weakness after Bexagliflozin (Bexacat) 75 reports · 1.9% of its reports
Weakness after Insulin 97 reports · 2.6% of its reports
Weakness after Methimazole 50 reports · 2.8% of its reports

All reported side effects of Velagliflozin in cats · Medicines most reported with weakness